Quick Takeaways
- Eric Aguiar has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $297,591.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Eric Aguiar
- Location
- New York, NY
- Summary
- The estimated net worth of Eric Aguiar is at least $297,591 dollars as of 24 Jun 2025. Eric Aguiar is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $216.4K. Eric Aguiar is the Director of Invitae Corp and owns shares of Invitae Corp stock worth about $81.2K.
- Signature
- /s/ Eric Aguiar, M.D.
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Eric Aguiar and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: BridgeBio Pharma, Inc. ($216,382).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Eric Aguiar
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Director | $216,382 | 20 Jun 2025 | ||
| NVTA | Invitae Corp | Director | $81,209 | 27 Apr 2023 | ||
| BMEA | Biomea Fusion, Inc. | Director | 11 Jun 2025 |
Insider Transactions Reported by Eric Aguiar:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.